Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer Meeting Abstract


Authors: Drilon, A.; Moreno, V.; Patel, J.; Lassen, U. N.; Solomon, B.; Rosen, L.; Leyvraz, S.; Tan, D. S. W.; Reeves, J. A.; Dima, L.; Brega, N.; Kummar, S.; Farago, A. F.
Abstract Title: Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer
Meeting Title: ESMO Virtual Congress 2020
Journal Title: Annals of Oncology
Volume: 31
Issue: Suppl. 4
Meeting Dates: 2020 Sep 19-21/Oct 16-18
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2020-09-01
Start Page: S834
Language: English
ACCESSION: WOS:000573469101575
DOI: 10.1016/j.annonc.2020.08.1603
PROVIDER: wos
Notes: Meeting Abstract: 1289P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon